The Summit

9th - 11th September 2013

NG30 Drug Discovery Europe

Summit Venue
Mirasierra Hotel, Madrid

The Next Generation Summit Europe is designed to bridge the growing technological gap between drug discovery and drug development.

  • Previous Summits

When I was asked to participate in this event as a delegate, I was quite sceptical about the value of this event to me, my group and my company. However, this view has completely changed – the networking opportunities were excellent, sharing of knowledge and experiences was good and un-pressured interactions with solution providers were very useful. I would be happy to recommend future events to my colleagues.

George Okafu, GSK

Video Testimonials

Find out what our clients think of the summits

More Videos

This meeting was extremely well organised (no meeting, keynote or workshop went overtime) and provided an interesting view in the different phases of drug development. Definitely worth attending.

Adri Kok, Teva Pharmaceuticals Industries

Very well organised at a nice location with time built in for networking. The one to one meetings have been very productive.

Rasmus Jorgensen, Novo Nordisk

Great opportunity for exchange and discussion on current needs and forces in the pharma industry in an open and constructive environment.

Ot. Armin Bauer, sanofi–aventis

I really enjoyed the event, which I felt was excellently organised, with a very well chosen delegation and with a superb and friendly service from the NGP Guys.

Santi Domínguez Vivero, Mestrelab Research

A well rounded meeting bringing senior experts together from across the drug discovery continuum.

David Gray, Drug Discovery Unit, University of Dundee

Excellent meeting, informative, honest and friendly with lots of opportunity for networking. I learned a lot, made many new contacts and treated very well.

David Heard, Novartis

Refreshingly exciting blend of science, technology, process and vendor solutions/discussions. Highly recommended, an excellent format and a valuable 2-day deep dive into the full breadth of key issues in drug discovery and development.

Dr Alexander Alanine, F.Hoffmann-La Roche

One on one meetings exceeded expectations. Excellent logistics management and organisation by NGP DD staff.

Gregg Mayer, Future DX